
News|Videos|September 1, 2020
Diana Isaacs, PharmD: An Overview of Insulin Affordability in 2020
Insulin affordability is an ongoing discussion topic for patients with diabetes and their care providers. The already difficult issue has been further compounded by the ongoing COVID-19 pandemic.
Advertisement
In the following interview, Diana Isaacs, PharmD, a clinical pharmacist and diabetes care and education specialist at the Cleveland Clinic, discusses the affordability of insulin and how the ability of patients to afford their medications has been impacted by the pandemic.
A leader in her field, Isaacs offers perspective on topics from how to approach these delicate conversations with patients to the best resources for patients who may be struggling to afford their insulin.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Pfizer-BioNTech XFG-Adapted COVID-19 Vaccine for 2026-27 Season
2
Intensive Blood Pressure Control in Primary Care May Lower Dementia Risk
3
Diagnosing PMOS in Adolescents: Criteria, Ultrasound Limits, and Red Flags
4
Independent Review Supports Respiratory Virus Immunizations for 2026-27 Season
5




























































































































